Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CDK5 |
| Upstream (Parents) |
|---|
| (<<) ADRBK1 → CDK5 |
| (<<) DPH2 → CDK5 |
| (<<) ELOVL1 → CDK5 |
| (<<) EPHA1 → CDK5 |
| (<<) GRPEL1 → CDK5 |
| (<<) GSTK1 → CDK5 |
| (<<) HOXA3 → CDK5 |
| (<<) KCTD5 → CDK5 |
| (<<) LIMK1 → CDK5 |
| (<<) LOC284542 → CDK5 |
| (<<) PDE4C → CDK5 |
| (<<) PPIF → CDK5 |
| (<<) RARG → CDK5 |
| (<<) RDH16 → CDK5 |
| (<<) RORA → CDK5 |
| (<<) SH3GLB2 → CDK5 |
| (<<) SYK → CDK5 |
| (<<) VIM → CDK5 |
| (<<) YRDC → CDK5 |
| (<<) ZNF467 → CDK5 |
| Downstream (Children) |
|---|
| CDK5 → CALML5 (>>) |
| CDK5 → CEACAM1 (>>) |
| CDK5 → DHCR7 (>>) |
| CDK5 → DYRK1A (>>) |
| CDK5 → ELF5 (>>) |
| CDK5 → FGFR2 (>>) |
| CDK5 → GNA12 (>>) |
| CDK5 → HDAC3 (>>) |
| CDK5 → HK1 (>>) |
| CDK5 → KREMEN2 (>>) |
| CDK5 → MYL5 (>>) |
| CDK5 → NFIB (>>) |
| CDK5 → NOS3 (>>) |
| CDK5 → NRN1 (>>) |
| CDK5 → PCSK7 (>>) |
| CDK5 → PDIA4 (>>) |
| CDK5 → PRR7 (>>) |
| CDK5 → STX1A (>>) |
